Skip to main navigation Skip to search Skip to main content

Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Acquired amegakaryocytic thrombocytopenia (AAMT) is a rare hematological disorder characterized by prolonged, severe thrombocytopenia, and reduced megakaryocytes on otherwise normal bone marrow biopsy. We report three cases of which two ultimately responded to treatment with eltrombopag, and one who one succumbed to illness despite treatment with multiple agents. These cases emphasize the difficulty of diagnosis and treatment of this rare condition.

Original languageEnglish
Article number300713
JournalHuman Pathology Reports
Volume33
DOIs
StatePublished - Sep 2023

Bibliographical note

Publisher Copyright:
© 2023 The Author(s)

Funding

Thanks to these individuals for their insightful clinical expertise: Dr. Rick McClure, Dr. Fevzi Yalniz, Dr. Thomas Gal, and Dr. Fadi al Nimri. Contribution: A.A. and Z.C. conceived of the presented idea. A.A. wrote the manuscript with support and editing from A.Q. and Z.C. A.Q. and Z.C. supervised the project and cared for the patients. D.W. and M.K. reviewed histological samples and provided images. All authors discussed the results and contributed to the final manuscript. Informed consent was obtained from all three patients involved in this case series. They were provided information and had had the opportunity to ask questions. The patients consented to publication of information about them in a journal or thesis.

Keywords

  • Diminished or absent megakaryopoiesis
  • Platelet disorder
  • Rare hematological condition

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia'. Together they form a unique fingerprint.

Cite this